Cirrhosis of liver: Comparative cross reactivity for quantification of SERPINA4/Kallistatin

Research Article | DOI: https://doi.org/10.31579/2768-0487/005

Cirrhosis of liver: Comparative cross reactivity for quantification of SERPINA4/Kallistatin

  • Shashidhar KN MBBS, MD ID 1
  • Lakshmaiah V MBBS, MD ID 2
  • Muninarayana C MBBS, MD ID 3
  • Krishna Sumanth Nallagangula * PhD ID 4

1 Department of Biochemistry, Sri Devaraj Urs Medical College, SDUAHER, Tamaka, Kolar, Karnataka, India.
2 Department of Community Medicine Sri Devaraj Urs Medical College SDUAHER Tamaka, Kolar Karnataka, India .
3 Department of Medicine Sri Devaraj Urs Medical College SDUAHER Tamaka, Kolar Karnataka, India.
4 Department of Community Medicine Sri Devaraj Urs Medical College SDUAHER Tamaka, Kolar Karnataka, India.

*Corresponding Author: Krishna Sumanth Nallagangula, Department of Biochemistry Sri Devaraj Urs Medical College SDUAHER Tamaka, Kolar Karnataka, India.

Citation: Shashidhar KN, Lakshmaiah V, Muninarayana C, and Krishna S Nallagangula. (2021) Cirrhosis of liver: Comparative cross reactivity for quantification of SERPINA4/Kallistatin. Journal of Clinical and Laboratory Research; 2(1); DOI:10.31579/2768-0487/005

Copyright: © 2021, Krishna Sumanth Nallagangula, This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Received: 27 January 2021 | Accepted: 15 February 2021 | Published: 19 February 2021

Keywords: cirrhosis of liver; serpina4/kallistatin; olyclonal; monospecific antibodies

Abstract

Cirrhosis of liver is an end stage of chronic liver insults from varied etiologies which leads to impaired liver functions. Proteins expressed from liver and enters into circulation reflects degree of liver dysfunction. Serpins (Serine protease inhibitors) are class of plasma proteins expressed from liver; SERPINA4/Kallistatin is a multifunctional serpin clade A protein expressed from liver and concentration in serum is the reflection of extent of liver dysfunction.  The present study aimed to compare cross reactivity of serpins for polyclonal and monospecific antibodies in both cirrhotic liver and healthy subjects. Blood samples were collected from 20 subjects (10 cirrhotic liver, 10 healthy) from R. L. Jalappa Hospital and Research Centre, Kolar, Karnataka, India. Separation of proteins was carried out by SDS-PAGE. Cross reactivity study was analyzed using western blot. Proteins present in cirrhotic liver and healthy subject’s serum were separated by SDS PAGE. There was no band detection on both (cirrhotic liver and healthy) PVDF (polyvinylidene diflouride) membranes with polyclonal antibodies. However, a significant band was observed with protein of interest in healthy PVDF membrane with monospecific antibodies. There was no band in cirrhotic liver PVDF membrane even with monospecific antibodies.  Comparative cross reactivity analysis of serpins in quantification of SERPINA4/Kallistatin in the present study demonstrated that there will not be any immunological cross reactivity between serpins and SERPINA4/Kallistatin due to the absence of identical epitope in cirrhotic liver and healthy subjects.

Introduction

Cirrhosis of liver is reversible natural wound healing response which results in the formation of abnormal continuation of connective tissue production and deposition and regenerative nodular formation in response to chronic liver injury [1, 2]. It is an end result of chronic liver insults from varied etiologies with similar pathological characteristics viz., degeneration, necrosis of hepatocytes, replacement of parenchyma by fibrotic tissue, regenerative nodules which leads to portal hypertension and finally liver failure [3]. Proteins which are expressed from liver and enters into circulation reflects degree of liver dysfunction and give potential insights for diagnosis of the disease [4]. 

Serpins (Serine Protease Inhibitors); plasma proteins mainly expressed from liver have similar structure and diverse functions [5]. With poor sequence homology; serpins share highly conserved core structure which is crucial for their inhibitory function [6]. Serpins exist as monomeric proteins in their native state. Reactive centre loop (RCL) of these proteins in secondary structure interacts with active site of proteases and inhibits their action. They undergo conformational changes in their structure which is crucial for their activity. Apart from inhibitory action, they acts as transporters for hormones, plays an important role in coagulation and blood pressure regulation [5].

Sequence similarity of serpins divided them into clades. Clades A to I in humans have 36 serpin coding genes and 5 pseudogenes. Clade A molecules are localized on chromosomes 1, 14 and X which are extracellular. Clade B serpins which are intracellular localized on chromosome 6 and 18. Clades A serpins are localized on chromosome 14 which are mainly expressed from liver (Table 1) [7, 8].

Table 1: Classification of SERPIN Clade A and chromosomal location

Kallistatin (SERPINA4, serpin family A member 4, tissue kallikrein inhibitor), belongs to clade A serpins; an acidic glycoprotein with a molecular weight of 58kD and isoelectric pH ranges from 4.6 to 5.2.  It is mainly expressed from liver cell (Hep G2 and Hep 3B) and encoded by the SERPINA4 gene with 5 exons and 4 introns mapped to chromosome 14q31-32.1 [9, 10]. Multifunctional protein, SERPINA4/Kallistatin shows inhibitory action on human tissue kallikrein [11]. SERPINA4/Kallistatin expressed from liver enters into circulation and concentrations vary in different chronic liver diseases (fibrosis, cirrhosis and hepatocellular carcinoma) [12].

Interference of serpins in quantification of SERPINA4/Kallistatin with antibodies may mislead the diagnosis of extent of the chronic liver disease. Hence, in the present study, an attempt has been made to identify immunological cross reactivity between SERPINA4/Kallistatin and other serpins for polyclonal and monospecific (monoclonal alternative) antibodies in cirrhotic liver and compared with healthy subjects. 

Materials and Methods

Samples

Blood samples were collected from 20 subjects: 10 clinically and diagnostically proven cirrhotic liver subjects with varying degree and varied etiology; age and gender matched 10 healthy subjects (Table 2) from R. L. Jalappa Hospital and Research Centre, attached to Sri Devaraj Urs Medical College, A constituent institute of Sri Devaraj Urs Academy of Higher Education and Research, Kolar, Karnataka, India. Individuals diagnosed with cirrhosis of liver caused by alcoholic liver disease (ALD) and non-alcoholic fatty liver diseases (NAFLD)  based on clinical history and symptoms viz., ascites, encephalopathy, jaundice and altered biochemical parameters were included in the study. Individuals with diabetes and/or its complications, myocardial infarction, acute and chronic renal failure, pneumonia and cancer were excluded from the study. Collection of blood samples from cirrhotic liver and healthy subjects was carried out after obtaining informed consent and study is approved by Institutional Ethical Committee (DMC/KLR/IEC/61/2016-17).

Table 2: Details of 20 subjects (10 liver cirrhotic cases, 10 healthy age and gender matched controls) used for cross reactivity analysisAbbreviations: C: Control; D: Diseased; M: Male; F: Female; NA: Not Applicable; ALD: Alcoholic Liver Disease; NAFLD: Non Alcoholic Fatty Liver Disease

Serum separation
Serum was separated from clotted blood using serum separator tubes centrifuged at 4000 rpm for 10 minutes. Serum was stored at – 20oC for further analysis. All the samples were used to find out cross reactivity of other serpins with SERPINA4/Kallistatin for polyclonal and monospecific (monoclonal alternative) antibodies by western blot after protein segregation by sodium dodecyl sulphate polyacrylamide gel electrophoresis (SDS-PAGE). 

Reagents
Primary polyclonal and monospecific (monoclonal alternative) antibodies specific for SERPINA/Kallistatin along with secondary antibodies conjugated with HRP specific for primary antibodies were procured from R&D systems, USA. Other chemicals of analytical grade were procured from Bio-Rad and Sigma Aldrich, USA.

SDS-PAGE
SDS gels were prepared as per standard protocol. Cirrhotic liver and healthy subject’s serum samples were loaded in different gels (two sets; for polyclonal and monospecific antibodies) and SDS-PAGE was carried with duplication at 25 mA per gel in 1x SDS running buffer. After electrophoresis, gels were incubated in fixing solution (7

Results

Immunological cross reactivity analysis by using polyclonal antibodies

Proteins were separated according to molecular weight in both diseased (D1 to D10) and healthy (C1 to C10) by using SDS-PAGE along with corresponding molecular weight marker. Western blot analysis allowed identification of cross reactivity of serpins with SERPINA4/Kallistatin in diseased and healthy samples by using polyclonal antibodies specific for SERPINA4/Kallistatin followed by secondary antibodies conjugated with HRP. 

PVDF membranes of both cirrhotic liver and healthy did not show any band which revealed that there will not be any cross reactivity of other serpins with polyclonal antibodies specific for SERPINA4/Kallistastin (Figure 1). However, polyclonal antibodies with more sensitivity were failed to capture SERPINA4/Kallistatin in both cirrhotic and healthy subjects. 

Figure 1: Western blot analysis for immunological cross reactivity with polyclonal antibodiesA: Western blot with diseased serum; M: Pre stained marker; D: Diseased subjects (D1 to D10; cirrhosis of liver); B: Western blot with control serum; C: Healthy subjects (C1 to C10)

Immunological cross reactivity analysis by using monospecific (monoclonal alternative) antibodies

Separation of proteins according to molecular weight was achieved by using SDS-PAGE along with pre-stained molecular marker in both healthy (C1 to C10) and diseased (D1 to D10) samples. Western blot analysis allowed identification of cross reactivity of serpins with SERPINA4/Kallistatin in diseased and healthy samples using monospecific (monoclonal alternative) antibodies specific for SERPINA4/Kallistatin followed by secondary antibodies conjugated with HRP. 

PVDF membrane of healthy (Figure 2) showed bands corresponding to SERPINA4/Kallistatin molecular weight revealed that monospecific antibodies have ability to capture protein of interest which is in pg/mL. However, no other bands were observed in healthy PVDF membranes which indicate that there will not be any cross reactivity of other serpins with monospecific (monoclonal alternative) antibodies.

Figure 2: Western blot analysis for immunological cross reactivity with monospecific (monoclonal alternative) antibodiesA: Western blot with healthy serum; M: Pre stained marker; C: Healthy subjects (C1 to C10); B: Western blot with control serum; D: Diseased subjects (D1 to D10; cirrhosis of liver)

Cirrhotic liver PVDF membrane did not show any band corresponding to molecular weight of SERPINA4/Kallistatin which revealed that there will be decreased concentration of SERPINA4/Kallistatin in cirrhotic liver subjects when compared to healthy subjects. There were no other bands in cirrhotic liver PVDF membrane that showed no cross reactivity of other SERPINs with SERPINA4/Kallistatin. 

Discussion

Study of human biology and disease in respect to proteomic studies is a major practical challenge due to lack of well validated antibodies to many of the human proteins [17]. Protein affinity reagents are fundamental tools for basic and wide range of applications in biomedical research [18]. In human protein atlas, 80% of the antibodies are polyclonal antibodies which imply binding to multiple epitopes which increase the risk of cross specificity towards other proteins. Cross reactivity for antibodies is a major problem in diagnostic and therapeutic application; essential to measure cross reactivity of given antibody against full proteome by using western blot, immunohistochemistry, immunofluorescence or sandwich immunoassays [19, 20]. 

Proteins share stretches of their primary structure which is identical or differ only by few amino acid residues and some proteins with similar functions have domains with surface patches of high similarities. An antibody targeting an epitope in one of these regions shows cross reactivity to other proteins than the intended target, making the results from an assay with this antibody unreliable and hard to interpret. Availability of well characterized antibodies provides valuable resource for diagnostic studies of the corresponding protein [21]. Mapping of linear epitopes of a polyclonal antibody followed by sequential epitope specific capture using synthetic peptides generates single epitope specific antibodies i.e. monospecific (monoclonal alternative) antibodies [19].

In our previous study using monoclonal antibodies to rule out cross reactivity, serpins did not show any cross reactivity with antibodies specific for SERPINA4/Kallistatin due to absence of identical epitope despite similarity in chemical properties, minor amino acids sequence resemblance and mapped on same gene. But due to less sensitivity (5ng/lane), monoclonal antibodies failed to capture protein of interest both in cirrhotic and healthy PVDF membranes. Multifactorial liver cirrhosis may not induce polymerization which directs to share identical epitope of serpins. This might be the reason for no cross reactivity in cirrhotic liver subjects [8].

Polyclonal antibodies have ability to recognize multiple epitopes, in the present study; these antibodies specific for SERPINA4/Kallistatin did not cross react with other serpins. Even though they are more sensitive; failed to capture protein of interest in both cirrhotic liver and healthy PVDF membranes whose concentrations are in pictogram/mL. Sequential affinity purification of polyclonal antibodies will generate epitope specific antibodies (monospecific antibodies) based on epitope mapping by using synthetic peptides [19]. 

Monospecific (monoclonal alternative) antibodies specific for SERPINA4/Kallistatin also did not exhibit cross reactivity with other serpins in both cirrhotic and healthy PVDF membranes in present study. These antibodies were able to capture protein of interest in healthy PVDF membranes. But they failed to capture SERPINA4/Kallistatin in cirrhotic liver PVDF membranes. Due to decreased synthetic capacity of liver in cirrhosis, concentrations of SERPINA4/Kallistatin might be decreased in circulation. This could be the reason for no band formation in cirrhotic PVDF membranes even with monospecific (monoclonal alternative) antibodies. On the other hand, renaturation of target protein in western blot analysis might be the reason for no band formation. This limitation could be overcome in Enzyme Linked Immuno Sorbant Assay (ELISA) as native protein is going to bind with specific antibodies in quantification analysis [19]. 

Comparison of cross reactivity analysis with polyclonal and monospecific (monoclonal alternative) antibodies concluded that serpins do not cross reactive with antibodies specific for SERPINA4/Kallistatin.  Monospecific (monoclonal alternative) antibodies are more sensitive and more specific with single linear specific epitope to form double sandwich quantitative ELISA than polyclonal antibodies. Monospecific (monoclonal alternative) antibodies are well characterized antibodies for protein studies especially in clinical diagnosis to capture protein of interest whose concentrations will be in pg/mL. During ELISA development, validation of newly developed methodology should be carried out to check interference of other factors (buffer components, sample matrix, compliment and rheumatoid factor). Further quantitative studies of Kallistatin may provide potential insights for diagnosis of chronic liver diseases [8, 22].

Conclusion

Comparative cross reactivity analysis of serpins in quantification of SERPINA4/Kallistatin in the present study demonstrated that there will not be any immunological cross reactivity between serpins and SERPINA4/Kallistatin due to the absence of identical epitope in cirrhotic liver and healthy subjects. Monospecific (monoclonal alternative) antibodies are well characterized antibodies with single linear specific epitope in the development of quantitative ELISA for protein studies especially in clinical diagnosis which are capable to capture protein of interest whose concentrations are in pg/mL; high sensitivity and high specificity.  

Funding

This research did not receive any specific grant from funding agencies in the public, commercial, or not-for-profit sectors.

Conflict of interest

Authors declare no conflict of interest.

References

Clearly Auctoresonline and particularly Psychology and Mental Health Care Journal is dedicated to improving health care services for individuals and populations. The editorial boards' ability to efficiently recognize and share the global importance of health literacy with a variety of stakeholders. Auctoresonline publishing platform can be used to facilitate of optimal client-based services and should be added to health care professionals' repertoire of evidence-based health care resources.

img

Virginia E. Koenig

Journal of Clinical Cardiology and Cardiovascular Intervention The submission and review process was adequate. However I think that the publication total value should have been enlightened in early fases. Thank you for all.

img

Delcio G Silva Junior

Journal of Women Health Care and Issues By the present mail, I want to say thank to you and tour colleagues for facilitating my published article. Specially thank you for the peer review process, support from the editorial office. I appreciate positively the quality of your journal.

img

Ziemlé Clément Méda

Journal of Clinical Research and Reports I would be very delighted to submit my testimonial regarding the reviewer board and the editorial office. The reviewer board were accurate and helpful regarding any modifications for my manuscript. And the editorial office were very helpful and supportive in contacting and monitoring with any update and offering help. It was my pleasure to contribute with your promising Journal and I am looking forward for more collaboration.

img

Mina Sherif Soliman Georgy

We would like to thank the Journal of Thoracic Disease and Cardiothoracic Surgery because of the services they provided us for our articles. The peer-review process was done in a very excellent time manner, and the opinions of the reviewers helped us to improve our manuscript further. The editorial office had an outstanding correspondence with us and guided us in many ways. During a hard time of the pandemic that is affecting every one of us tremendously, the editorial office helped us make everything easier for publishing scientific work. Hope for a more scientific relationship with your Journal.

img

Layla Shojaie

The peer-review process which consisted high quality queries on the paper. I did answer six reviewers’ questions and comments before the paper was accepted. The support from the editorial office is excellent.

img

Sing-yung Wu

Journal of Neuroscience and Neurological Surgery. I had the experience of publishing a research article recently. The whole process was simple from submission to publication. The reviewers made specific and valuable recommendations and corrections that improved the quality of my publication. I strongly recommend this Journal.

img

Orlando Villarreal

Dr. Katarzyna Byczkowska My testimonial covering: "The peer review process is quick and effective. The support from the editorial office is very professional and friendly. Quality of the Clinical Cardiology and Cardiovascular Interventions is scientific and publishes ground-breaking research on cardiology that is useful for other professionals in the field.

img

Katarzyna Byczkowska

Thank you most sincerely, with regard to the support you have given in relation to the reviewing process and the processing of my article entitled "Large Cell Neuroendocrine Carcinoma of The Prostate Gland: A Review and Update" for publication in your esteemed Journal, Journal of Cancer Research and Cellular Therapeutics". The editorial team has been very supportive.

img

Anthony Kodzo-Grey Venyo

Testimony of Journal of Clinical Otorhinolaryngology: work with your Reviews has been a educational and constructive experience. The editorial office were very helpful and supportive. It was a pleasure to contribute to your Journal.

img

Pedro Marques Gomes

Dr. Bernard Terkimbi Utoo, I am happy to publish my scientific work in Journal of Women Health Care and Issues (JWHCI). The manuscript submission was seamless and peer review process was top notch. I was amazed that 4 reviewers worked on the manuscript which made it a highly technical, standard and excellent quality paper. I appreciate the format and consideration for the APC as well as the speed of publication. It is my pleasure to continue with this scientific relationship with the esteem JWHCI.

img

Bernard Terkimbi Utoo

This is an acknowledgment for peer reviewers, editorial board of Journal of Clinical Research and Reports. They show a lot of consideration for us as publishers for our research article “Evaluation of the different factors associated with side effects of COVID-19 vaccination on medical students, Mutah university, Al-Karak, Jordan”, in a very professional and easy way. This journal is one of outstanding medical journal.

img

Prof Sherif W Mansour

Dear Hao Jiang, to Journal of Nutrition and Food Processing We greatly appreciate the efficient, professional and rapid processing of our paper by your team. If there is anything else we should do, please do not hesitate to let us know. On behalf of my co-authors, we would like to express our great appreciation to editor and reviewers.

img

Hao Jiang

As an author who has recently published in the journal "Brain and Neurological Disorders". I am delighted to provide a testimonial on the peer review process, editorial office support, and the overall quality of the journal. The peer review process at Brain and Neurological Disorders is rigorous and meticulous, ensuring that only high-quality, evidence-based research is published. The reviewers are experts in their fields, and their comments and suggestions were constructive and helped improve the quality of my manuscript. The review process was timely and efficient, with clear communication from the editorial office at each stage. The support from the editorial office was exceptional throughout the entire process. The editorial staff was responsive, professional, and always willing to help. They provided valuable guidance on formatting, structure, and ethical considerations, making the submission process seamless. Moreover, they kept me informed about the status of my manuscript and provided timely updates, which made the process less stressful. The journal Brain and Neurological Disorders is of the highest quality, with a strong focus on publishing cutting-edge research in the field of neurology. The articles published in this journal are well-researched, rigorously peer-reviewed, and written by experts in the field. The journal maintains high standards, ensuring that readers are provided with the most up-to-date and reliable information on brain and neurological disorders. In conclusion, I had a wonderful experience publishing in Brain and Neurological Disorders. The peer review process was thorough, the editorial office provided exceptional support, and the journal's quality is second to none. I would highly recommend this journal to any researcher working in the field of neurology and brain disorders.

img

Dr Shiming Tang

Dear Agrippa Hilda, Journal of Neuroscience and Neurological Surgery, Editorial Coordinator, I trust this message finds you well. I want to extend my appreciation for considering my article for publication in your esteemed journal. I am pleased to provide a testimonial regarding the peer review process and the support received from your editorial office. The peer review process for my paper was carried out in a highly professional and thorough manner. The feedback and comments provided by the authors were constructive and very useful in improving the quality of the manuscript. This rigorous assessment process undoubtedly contributes to the high standards maintained by your journal.

img

Raed Mualem

International Journal of Clinical Case Reports and Reviews. I strongly recommend to consider submitting your work to this high-quality journal. The support and availability of the Editorial staff is outstanding and the review process was both efficient and rigorous.

img

Andreas Filippaios

Thank you very much for publishing my Research Article titled “Comparing Treatment Outcome Of Allergic Rhinitis Patients After Using Fluticasone Nasal Spray And Nasal Douching" in the Journal of Clinical Otorhinolaryngology. As Medical Professionals we are immensely benefited from study of various informative Articles and Papers published in this high quality Journal. I look forward to enriching my knowledge by regular study of the Journal and contribute my future work in the field of ENT through the Journal for use by the medical fraternity. The support from the Editorial office was excellent and very prompt. I also welcome the comments received from the readers of my Research Article.

img

Dr Suramya Dhamija

Dear Erica Kelsey, Editorial Coordinator of Cancer Research and Cellular Therapeutics Our team is very satisfied with the processing of our paper by your journal. That was fast, efficient, rigorous, but without unnecessary complications. We appreciated the very short time between the submission of the paper and its publication on line on your site.

img

Bruno Chauffert

I am very glad to say that the peer review process is very successful and fast and support from the Editorial Office. Therefore, I would like to continue our scientific relationship for a long time. And I especially thank you for your kindly attention towards my article. Have a good day!

img

Baheci Selen

"We recently published an article entitled “Influence of beta-Cyclodextrins upon the Degradation of Carbofuran Derivatives under Alkaline Conditions" in the Journal of “Pesticides and Biofertilizers” to show that the cyclodextrins protect the carbamates increasing their half-life time in the presence of basic conditions This will be very helpful to understand carbofuran behaviour in the analytical, agro-environmental and food areas. We greatly appreciated the interaction with the editor and the editorial team; we were particularly well accompanied during the course of the revision process, since all various steps towards publication were short and without delay".

img

Jesus Simal-Gandara

I would like to express my gratitude towards you process of article review and submission. I found this to be very fair and expedient. Your follow up has been excellent. I have many publications in national and international journal and your process has been one of the best so far. Keep up the great work.

img

Douglas Miyazaki

We are grateful for this opportunity to provide a glowing recommendation to the Journal of Psychiatry and Psychotherapy. We found that the editorial team were very supportive, helpful, kept us abreast of timelines and over all very professional in nature. The peer review process was rigorous, efficient and constructive that really enhanced our article submission. The experience with this journal remains one of our best ever and we look forward to providing future submissions in the near future.

img

Dr Griffith

I am very pleased to serve as EBM of the journal, I hope many years of my experience in stem cells can help the journal from one way or another. As we know, stem cells hold great potential for regenerative medicine, which are mostly used to promote the repair response of diseased, dysfunctional or injured tissue using stem cells or their derivatives. I think Stem Cell Research and Therapeutics International is a great platform to publish and share the understanding towards the biology and translational or clinical application of stem cells.

img

Dr Tong Ming Liu

I would like to give my testimony in the support I have got by the peer review process and to support the editorial office where they were of asset to support young author like me to be encouraged to publish their work in your respected journal and globalize and share knowledge across the globe. I really give my great gratitude to your journal and the peer review including the editorial office.

img

Husain Taha Radhi

I am delighted to publish our manuscript entitled "A Perspective on Cocaine Induced Stroke - Its Mechanisms and Management" in the Journal of Neuroscience and Neurological Surgery. The peer review process, support from the editorial office, and quality of the journal are excellent. The manuscripts published are of high quality and of excellent scientific value. I recommend this journal very much to colleagues.

img

S Munshi

Dr.Tania Muñoz, My experience as researcher and author of a review article in The Journal Clinical Cardiology and Interventions has been very enriching and stimulating. The editorial team is excellent, performs its work with absolute responsibility and delivery. They are proactive, dynamic and receptive to all proposals. Supporting at all times the vast universe of authors who choose them as an option for publication. The team of review specialists, members of the editorial board, are brilliant professionals, with remarkable performance in medical research and scientific methodology. Together they form a frontline team that consolidates the JCCI as a magnificent option for the publication and review of high-level medical articles and broad collective interest. I am honored to be able to share my review article and open to receive all your comments.

img

Tania Munoz

“The peer review process of JPMHC is quick and effective. Authors are benefited by good and professional reviewers with huge experience in the field of psychology and mental health. The support from the editorial office is very professional. People to contact to are friendly and happy to help and assist any query authors might have. Quality of the Journal is scientific and publishes ground-breaking research on mental health that is useful for other professionals in the field”.

img

George Varvatsoulias

Dear editorial department: On behalf of our team, I hereby certify the reliability and superiority of the International Journal of Clinical Case Reports and Reviews in the peer review process, editorial support, and journal quality. Firstly, the peer review process of the International Journal of Clinical Case Reports and Reviews is rigorous, fair, transparent, fast, and of high quality. The editorial department invites experts from relevant fields as anonymous reviewers to review all submitted manuscripts. These experts have rich academic backgrounds and experience, and can accurately evaluate the academic quality, originality, and suitability of manuscripts. The editorial department is committed to ensuring the rigor of the peer review process, while also making every effort to ensure a fast review cycle to meet the needs of authors and the academic community. Secondly, the editorial team of the International Journal of Clinical Case Reports and Reviews is composed of a group of senior scholars and professionals with rich experience and professional knowledge in related fields. The editorial department is committed to assisting authors in improving their manuscripts, ensuring their academic accuracy, clarity, and completeness. Editors actively collaborate with authors, providing useful suggestions and feedback to promote the improvement and development of the manuscript. We believe that the support of the editorial department is one of the key factors in ensuring the quality of the journal. Finally, the International Journal of Clinical Case Reports and Reviews is renowned for its high- quality articles and strict academic standards. The editorial department is committed to publishing innovative and academically valuable research results to promote the development and progress of related fields. The International Journal of Clinical Case Reports and Reviews is reasonably priced and ensures excellent service and quality ratio, allowing authors to obtain high-level academic publishing opportunities in an affordable manner. I hereby solemnly declare that the International Journal of Clinical Case Reports and Reviews has a high level of credibility and superiority in terms of peer review process, editorial support, reasonable fees, and journal quality. Sincerely, Rui Tao.

img

Rui Tao

Clinical Cardiology and Cardiovascular Interventions I testity the covering of the peer review process, support from the editorial office, and quality of the journal.

img

Khurram Arshad